IP Library Granted Patent US 9,157,976
Granted Patent B2
US 9,157,976 · App. 14/230,739 · Granted Oct 13, 2015

CEST MRI methods for imaging glutaminolysis in cancer

Inventors: Ravinder Reddy (Gladwyne, PA); Hari Hariharan (Mount Laurel, NJ); Catherine DeBrosse (Norristown, PA); Ravi Prakash Reddy Nanga (Secane, PA)
Assignee: The Trustees Of The University Of Pennsylvania
G01R33/4828G01R33/5601G01R33/5605
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,157,976
App. No.
14/230,739
Granted
Oct 13, 2015
Kind
B2
Abstract

CEST imaging technique and MR scanning are used as an MRI method for measuring glutaminase mediated tumors. The method takes advantage of the fact that glutamine does not exhibit a significant Chemical Exchange Saturation Transfer (CEST) effect while glutamate does. In accordance with this method, one first obtains a glutamate CEST MRI map of the area of a tumor. L-glutamine (nontoxic up to several millimolar level) or glutaminase blocker is then injected and a post injection Glutamate CEST map is obtained. The difference in the spatial maps indicates the level of expression of glutaminase in the tumor.

Claims (10)

1. A method of obtaining the level of expression of glutaminase in a tumor using MR imaging, comprising:

applying to a suspected tumor a Chemical Exchange Saturation Transfer (CEST) saturation pulse train at a range of frequency offsets around a frequency of exchangeable protons of glutamate as well as the same frequency offsets on the opposite of the water resonance;

MR imaging a slice of the body containing the suspected tumor to which the CEST saturation pulse has been applied to obtain a first glutamate CEST MRI map of the area of the tumor;

injecting L-glutamine or a glutaminase blocker into the tumor;

after injection of the L-glutamine or glutaminase blocker into the tumor, MR imaging a slice of the body containing the suspected tumor to which the CEST saturation pulse has been applied to obtain a second glutamate CEST MRI map of the area of the tumor;

determining a CEST contrast image by taking a ratio of a difference image obtained by subtraction of saturation images obtained during said MR imaging steps with saturation applied at both positive and negative frequencies with respect to water resonance and an image with no saturation; and

displaying the CEST contrast image as an indication of the level of expression of glutaminase in the tumor.

2. The method of claim 1 , further comprising adjusting an amplitude and duration of the CEST saturation pulse train based on the proton exchange rate of glutamate.

3. The method of claim 1 , wherein the CEST saturation pulse train comprises a variable number of pulses with variable shapes including rectangle and Hanning windowed rectangle, variable amplitudes, variable durations, and variable delays.

4. The method of claim 1 , further comprising B 0 and B 1 correcting the saturation images before subtracting said saturation images.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 18, 2014
From: REDDY, RAVINDER; HARIHARAN, HARI; DE BROSSE, CATHERINE; NANGA, RAVI PRAKASH REDDY
To: THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
Reel/Frame 033342/0979 →
Continuity (3)
Continuation In Part 13186981 · Jul 20, 2011
Provisional Application 61365871 · Jul 20, 2010
Related Publication 20140213887A1 · Jul 31, 2014